Skip to main content
BBH logo
BBH
(NASDAQ)
VanEck Biotech ETF
$210.67-- (--)
Loading... - Market loading

BBH ETF: VanEck Biotech ETF - Price, Holdings & Analysis

VanEck Biotech ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$204.31 - $208.03
52-Week High$212.54
52-Week Low$156.45
Open$204.31
Volume8.50K
Average Volume (3M)5.59K
Assets (AUM)397.07M
Expense Ratio0.35%
Total Holdings25
Inception DateDec 20, 2011
1 Day Change1.76%
1 Month Change-1.16%
6 Month Change4.28%
YTD Change9.28%
1 Year Change31.79%
52-Week Change25.85%
5 Year Change-3.00%
10 Year Change76.54%
50-Day MA$197.47
200-Day MA$191.45
RSI58.03
Stochastic %K72.30
Stochastic %D52.30
Annual Dividend$0.96
Dividend Yield0.46%
Last Dividend Ex-DateDec 26, 2026
Dividend Growth YoY-23.58%

Frequently Asked Questions About VanEck Biotech ETF

What is the current price of BBH?

The latest BBH price is $207.88. The 52-week range is $156.45–$212.54. BBH has returned 25.9% over the past 52 weeks.

What is the expense ratio for BBH?

BBH's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does BBH pay dividends?

Yes, BBH pays a 0.46% dividend yield. The last ex-dividend date was 2026-12-26. View full dividend history in the Dividends section.

What are the top holdings of BBH?

BBH's largest holdings are Amgen Inc. (15.8%), Gilead Sciences, Inc (13.2%), Vertex Pharmaceuticals Incorporated (8.7%) (combined weight: 37.7%). The fund holds 25 total positions. View the complete portfolio breakdown in the Holdings section.

How does BBH compare to similar ETFs?

Compare BBH (0.35% expense ratio, $397M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.